Bicarbonates for the Prevention of Postoperative Renal Failure in Endovascular Aortic Aneurysm Repair: A Randomized Pilot Trial

Table 4

(a) Baseline values and (b) percent variation from baseline at 3, 24, and 72 hours postcontrast media exposure in the patient who developed AKI, as opposed to those who did not.

(a)

	Serum			Urinary
	Creatinine; (µmol/L)	cysC; (ng/mL)	NGAL; (ng/mL)	IL-18; (pg/𝜇mol creatinine)	NAG; (IU/mmol creatinine)	NGAL; (ng/𝜇mol creatinine)	KIM-1; (ng/𝜇mol creatinine)
Baseline
AKI	62	775.90	106.50	3.50	0.20	1.10	0.149
No AKI	90.1	830.47	111.61	9.92	1.38	6.49	0.182

Values expressed as means.
AKI: acute kidney injury; cysC: cystatin C; IL-18: interleukin 18; KIM-1: kidney injury molecule 1; NAG: N-acetyl-𝛽-D-glucosaminidase; NGAL: neutrophil gelatinase-associated lipocalin.

(b)

	Serum			Urinary
	Creatinine; (µmol/L)	cysC; (ng/mL)	NGAL; (ng/mL)	IL-18; (pg/𝜇mol creatinine)	NAG; (IU/mmol creatinine)	NGAL; (ng/𝜇mol creatinine)	KIM-1; (ng/𝜇mol creatinine)
Δ3 h (%)
AKI	69.68	33.78	30.70	3854.28	11550.00	10700.00	−34.23
No AKI	−23.88	−7.91	2.33	17.76	940.38	271.66	22.66
Δ24 h (%)
AKI	66.13	3.45	87.61	1217.14	2150.00	7818.18	161.74
No AKI	−15.31	1.99	9.51	298.28	728.48	400.23	168.85
Δ48 h (%)
AKI	75.81	54.71	286.20	2282.86	3200.00	22281.82	296.64
No AKI	−12.72	8.81	6.14	316.51	1211.74	658.79	243.75

Values expressed as mean percent change from baseline.
AKI: acute kidney injury; cysC: cystatin C; IL-18: interleukin 18; KIM-1: kidney injury molecule 1; NAG: N-acetyl-𝛽-D-glucosaminidase; NGAL: neutrophil gelatinase-associated lipocalin.